NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Bone Grafts - A US Market Analysis
http://www.reportlinker.com/p0164259/Bone-Grafts---A-US-Market-Analysis.html
Globally, approximately one million bone-grafting procedures are performed every year on the pelvis, spine, and other body extremities. Higher incidence of bone and joint related disorders such as osteoporosis, arthritis, and other diseases such as obesity, diabetes, and cancer, cause injury to orthopedic tissues and affect the health and capability of the human skeleton. Bone and joint disorders account for almost half of debilitating conditions in individuals over 50 years of age. With this cohort of the population expected to continue to increase, demographics alone will represent a key growth driver. In addition, market for bone grafts will continue to be driven by the risks associated with the use of autograft bone, the need to achieve superior and optimum bone fusion, speedy patient recovery, need to eliminate multiple surgeries (in case of bone harvesting from the patient), rising number of spinal fusion procedures, growing use of tissue-engineered bone in joint replacements, commercialization of new, next generation bone growth factors, and launch of innovative new bone products, among others.
These and other market data and trends are presented in "Bone Grafts: A US Market Analysis" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
BONE GRAFTS BMR-1059
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. MARKET OVERVIEW AND OUTLOOK 3
Bone Grafts: A Prelude 3
Orthobiologics Gain Traction in the Bone Grafts Market 4
Statistical Insights Into the World Orthopaedic Implants Market 5
Hospital Pricing, Not GDP is the Key Driver of Growth 6
Orthopedic Implant Pricing Grows Independent of Medicare
Reimbursement: Why? 7
Medicare Reimbursement Higher for Spinal Fusion With
Growth Factors 7
Is Consolidation Blowing in the Wind? 8
Patient Safety Emerges to Become a Top Priority 8
Bone Grafts Termed as Tissues Suffer From Inconsistent Patient
Outcomes 8
What Drives Physicians' Choice of Bone Grafts? 9
Key Market Trends & Issues: A Review 9
Aging Population: A Strong Demographic Driver 9
Rising Incidences of Degenerative Intervertebral Disc Diseases 10
Rise in Revision Orthopaedic Surgeries 11
Rise in Spinal Fusions in Private Healthcare 11
Increasing Visibility of Orthobiological Products to Spur
Grafting Options 11
Precision Machined Allograft Gain Surgeon Preference 11
Strong Prices Will Continue to Characterize Bone Graft
Technologies 12
Unmet Clinical Needs to Foster R&D Engine 12
Synthetic Bone Grafts To Fan Growth 12
Dental Bone Grafts On the Rise 13
Alliances with Organ Procurement Organizations: A Shot in the
Arm 13
Advanced Allografts Encroaching into the Use of Autografts
in Surgical Procedures 14
DBM: Strong Growth But Tough Competition 14
Adequate Reimbursement: An Impetus for Growth & Profitability 14
Aging Baby Boomers Render a Decreased Donor Pool 15
Limited Availability of Donor Tissues 15
Intense Competition from Alternative Tissue Repair Therapies 16
Substitute Technologies Threaten to Replace Spinal Fusions 16
Growing Off-Label Use of Infuse Bone Graft Raises Eyebrows 17
Technology Innovations in Orthopedic Biomaterials: The Way to Go! 17
MPCs: Offer Promising Breakthroughs in Bone-Graft Substitute 17
Peptide Signaling Molecules to the Rescue 18
Prostaglandin Agonists: Emerging From their Drawbacks 18
Platelet Concentrate Systems 18
Synthetic Bone Grafts 19
Combination of Bone Marrow and Bone Graft Substitute 19
Stem Cell Therapy 20
Bone Morphogenetic Proteins 20
GEM OS®1 Shows Promise 21
geneX® Synthetic Bone Graft Substitute 21
ACCELL Total Bone Matrix 21
Tissue Recovery & Processing: A Structural Review 21
Tissue Banks 21
Tissue Processing 23
Tissue Distribution 24
An Illustration of the Tissue Recovering, Processing, &
Distribution Network 25
3. COMPETITION 25
Competitive Scenario: A Primer 25
The New Batting Order in Key Product Markets in the US 26
Standard Bone Allografts 26
Machined Bone Allografts 27
Demineralized Bone Matrix (DBM) 27
Synthetic Bone Graft Substitutes 28
Platelet Concentration Systems 29
Allograft Tendon/Ligament 29
Spinal Fusion 29
The New Batting Order in Key Product Markets in Europe 30
Acceptance of Synthetic Bone Grafts in Europe: An Uphill Task 30
EU directive 2003/32/EC 30
DBM-based Products in Europe & Rest of World 30
Standard Bone Allografts 31
Machined Bone Allografts 31
Demineralised Bone Matrix Market 32
Bone Graft Substitutes Market: 32
4. REGULATORY ENVIRONMENT & REIMBURSEMENTS 33
Regulatory Issues 33
FDA Classification of Bone Products 33
Human Cells, Tissues and Cellular and Tissue-Based Products
(HCT/Ps) 33
National Organ Transplant Act (NOTA) 34
Good Tissue Practices 34
Tissue Banking Regulation 35
FDA Regulations on Xenograft 35
DBM-based Products in US 35
Synthetic Bone Graft Substitutes 35
Reimbursement Issues 35
CMS Implements 2008 Hospital IPPS 35
CMS Proposal for 2007 Hospital IPPS 36
(i) Fracture Treatment 36
(ii) C-codes for Spine Devices 36
(iii) Revised Payment Rates for DRG 497, 498 37
5. PRODUCT FACTS 37
A. Standard Allografts 37
B. Machined Bone Allografts 37
C. Demineralized Bone Matrix (DBM) 38
D. Bone Morphogenetic Protein (BMP) 38
E. Platelet Concentrators 38
F. Synthetic Bone Grafts 38
6. CORPORATE DEVELOPMENTS 39
Regeneration Technologies Merges with Tutogen Medical 39
Wright Medical Takes Over INBONE Technologies 39
NuVasive Acquires Osteocel Biologics 39
Integra LifeSciences Takes Over Theken 39
Osteotech Inks Distribution Contract with BioHorizons 39
Pioneer Surgical Secures FDA Approval for FortrOss 40
Inion Secures FDA Approval for Biodegradable Spine Products 40
Biocomposites Bags FDA Approval for geneX® Putty 40
IFGL Establishes Dental BioGraft Plant 40
Osteotech Receives FDA Approval for Plexur M™ Biocomposite 40
RTI Biologics Introduces CopiOs Implant for Dental Procedures 40
ETEX Unveils 'EquivaBone' Bone Graft Substitute 41
NovaBone Introduces New Type of Synthetic Bone Graft 41
Pioneer® Surgical Unleashes FortrOss™ 41
Alphatec Launches ProFUSE 41
Medtronic Releases Nanostim Synthetic Bone Paste 41
NovaBone Unveils 'NovaBone Putty' 42
RTI Introduces Fresh-Stored OC Allograft Range 42
Integra LifeSciences Unveils Smaller Size 'Accell TBM® 42
Orthovita Launches VITOSS® Bioactive Foam Pack 42
NovaBone Launches 'NovaBone Porous Morsels' 42
Wright Medical Group Introduces BIOFOAM 43
Integra LifeSciences Releases Accell Evo3 43
Millenium Signs an Asset Sale Agreement with Two Companies 43
INBONE Technologies Merges with Reiley Orthopedic 43
AlloSource Signs a License Agreement with IsoTis 43
Osteotech Inks Single Source Agreement for Allograft Products 44
Bonesupport Enters Into Distribution Agreement with Signus
Medical 44
Tornier Takes Over DVO 44
Zimmer Holdings Acquires Endius Inc. 44
Wright Medical Group Takes Over Darco International 44
Integra LifeSciences Completes Acquisition of IsoTis 45
Synthes Gets FDA Clearance for Bone Graft Substitute 45
Collagen Receives 510(k) Clearance from FDA for SynOss™ 45
ISTO Technologies Obtains 510(k) Clearance for InQu™ 45
RTI Signs Supply Contract with Stryker 45
RTI Signs a 10-Year Supply Agreement with Zimmer Holdings 46
Medtronic Sofamor Danek Receives FDA Approval for INFUSE 46
Smith and Nephew Acquires Plus Orthopedics 46
Medtronic Signs Development Agreement with OsteoGenix 46
NuVasive Buys Technology from Radius Medical 46
AlloSource Join Hands with Osiris 46
DePuy Spine Launches New Bone Graft Product 47
Medtronic Offers Progenix™ DBM Putty 47
Global Medical Launches Bone Graft Portfolio 47
Integra LifeSciences Introduces Mozaik™ 47
Collagen Unveils 'OssiMend™ Bone Graft Matrix 47
Wright Medical Launches PRO-DENSE Injectable Regenerative Graft 48
ApaTech Introduces Actifuse ABX Easyfill Putty 48
ApaTech Releases Actifuse E-Z-Prep 48
7. MAJOR PLAYERS 49
AlloSource (USA) 49
Biomet Inc (USA) 49
Interpore Cross International (USA) 49
BioMimetic Therapeutics Inc (USA) 49
DePuy Spine Inc (USA) 49
Exactech Inc (USA) 49
Integra LifeSciences Holdings Corporation (USA) 50
Integra OrthoBiologics (USA) 50
Lifelink Tissue Bank (USA) 50
LifeNet Health (USA) 50
Medtronic Inc (USA) 50
Medtronic Sofamor Danek Inc (USA) 50
Musculoskeletal Transplant Foundation (USA) 51
NovaBone Products LLC (USA) 51
NuVasive Inc (USA) 51
Orthovita Inc (USA) 51
Osiris Therapeutics Inc (USA) 51
Osteotech Inc (USA) 51
RTI Biologics, Inc. (USA) 52
Smith & Nephew Plc (UK) 52
Stryker Corporation (USA) 52
Synthes Inc (USA) 52
Wright Medical Technology, Inc (USA) 52
Zimmer Holdings, Inc (USA) 52
8. GLOBAL MARKET ANALYTICS 53
EXHIBITS
Table 1: Percentage Breakdown of Orthobiologics Manufacturer
Value Sales in the World - 2007
Table 2: Percentage Breakdown of Orthopaedic Manufacturer
Value Sales in the World - 2007
Table 3: Market Shares of Leading Companies in the Global
Market for Orthopaedic Implants in Spinal Procedures - 2007
Table 4: Market Shares of Leading Companies in the Global
Market for Orthopaedic Implants in Reconstructive Procedures -
2007
Table 5: Market Shares of Leading Companies in the Global
Market for Orthopaedic Implants in Trauma &
Craniomaxillofacial Procedures - 2007
Table 6: Breakdown of Osteoporotic Fractures by Site in the
US
Table 7: Payer Mix for Spinal (Cervical) Fusion Procedures in
the US
Table 8: Payer Mix for Spinal (Lumbar) Fusion Procedures in
the US
Table 9: Breakdown of Number of Tissue Processing Donors by
Select Processing Organization/Company in the US - 2006
Table 10: Leading Organizations/Companies in the US Tissue
Processing Market by Market Share- 2006
Table 11: Market Shares of Leading Tissue Processors in the US
Standard Bone Allografts Market - 2006
Table 12: Market Shares of Leading Tissue Processors in the US
Machined Bone Allografts Market - 2006
Table 13: Market Shares of Demineralized Bone Matrix
Manufacturer Value Sales in the US - 2006
Table 14: Market Shares of Synthetic Bone Graft Substitutes
Manufacturer Value Sales in the US - 2006
Table 15: Market Shares of Leading Platelet Concentration
Systems Manufacturer Value Sales in the US - 2006
Table 16: Market Shares of Leading Allograft Tendon/Ligament
Companies/Organizations in the US - 2006
Table 17: Market Shares of Spinal Fusion Manufacturers in the
US - 2006
Table 18: Market Shares of Leading Companies/Organizations in
the European Standard Bone Allografts Market - 2007
Table 19: Market Shares of Leading Companies/Organizations in
the European Machined Bone Allografts Market - 2007
Table 20: Market Shares of Leading Companies/Organizations in
the European Demineralized Bone Matrix Market - 2007
Table 21: Market Shares of Leading Players in the European
Bone Graft Substitutes Market - 2007
Table 22: Bone Grafts Market by Product Segment in the US:
2007-2015 (Sales in US$ Million)
Table 23: Percentage Breakdown of Bone Grafts Market by
Product Segment in the US for the Years 2009 & 2012
Table 24: Bone Grafts Market by End-Use Application in the US:
2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Bone Grafts Market by
End-Use Application in the US for the Years 2009 & 2012
COMPANIES PROFILED
To order this report:
Medical Equipment and Supply Industry: Bone Grafts - A US Market Analysis
Check our Company Profile, SWOT and Revenue Analysis!
Contact:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article